Moteur de recherche d’entreprises européennes
Financement de l’UE (4 938 216 €) : Un centre d’excellence en biomédecine computationnelle Hor25/07/2016 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
Un centre d’excellence en biomédecine computationnelle
This Centre of Excellence will advance the role of computationally based modelling and simulation within biomedicine. Three related user communities lie at the heart of the CoE: academic, industrial and clinical researchers who all wish to build, develop and extend such capabilities in line with the increasing power of high performance computers. Three distinct exemplar research areas will be pursued: cardiovascular, molecularly-based and neuro-musculoskeletal medicine. Predictive computational biomedicine involves applications that are comprised of multiple components, arranged as far as possible into automated workflows in which data is taken, from an individual patient, processed, and combined into a model which produces predicted health outcomes. Many of the models are multiscale, requiring the coupling of two or more high performance codes. Computational biomedicine holds out the prospect of predicting the effect of personalised medical treatments and interventions ahead of carrying them out, with all the ensuing benefits. Indeed, in some cases, it is already doing so today. The CoE presents a powerful consortium of partners and has an outward facing nature and will actively train, disseminate and engage with these user communities across Europe and beyond. Because this field is new and growing rapidly, it offers numerous innovative opportunities. There are three SMEs and three enterprises within the project, as well as eight associate partners drawn from across the biomedical sector, who are fully aware of the vast potential of HPC in this domain. We shall work with them to advance the exploitation of HPC and will engage closely with medical professionals through our partner hospitals in order to establish modeling and simulation as an integral part of clinical decision making. Our CoE is thus user-driven, integrated, multidisciplinary, and distributed; presenting a vision that is in line with the Work Programme.
| Acellera Labs SL | 95 881 € |
| Barcelona Supercomputing Center Centro Nacional de Supercomputacion | 372 076 € |
| Bull SAS | 138 044 € |
| CBK SCI Con Ltd. | 277 144 € |
| Evotec (UK) Ltd. | 131 288 € |
| Janssen-Cilag | 0,00 € |
| Janssen Pharmaceutica N.V. | 125 025 € |
| LIFETEC GROUP B.V. | 247 988 € |
| SURF B.V. | 495 950 € |
| The Chancellor, Masters and Scholars of the University of Oxford | 264 955 € |
| The University of Edinburgh | 335 831 € |
| The University of Sheffield | 456 369 € |
| Universidad Pompeu Fabra | 191 750 € |
| UNIVERSITE DE GENEVE | 388 225 € |
| UNIVERSITEIT VAN AMSTERDAM | 508 799 € |
| University College London | 908 893 € |
https://cordis.europa.eu/project/id/675451
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.
Les visualisations de "Acellera Labs SL - Financement de l’UE (4 938 216 €) : Un centre d’excellence en biomédecine computationnelle"
sont mis à disposition par
North Data
et peuvent être réutilisées selon les termes de la licence
Creative Commons CC-BY.
